Publications by authors named "Greg Koval"

Claim this Profile
P
Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial.
Nitin Jain, Emily Curran, Neil M Iyengar, Ernesto Diaz-Flores, Rangesh Kunnavakkam, Greg Koval

Clin Cancer Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia.
Robert E Gallagher, Barry K Moser, Janis Racevskis, Xavier Poiré, Clara D Bloomfield, Greg Koval

Blood· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909.
Hongtao Liu, Jeffrey L Johnson, Greg Koval, Greg Malnassy, Dorie Sher

Haematologica· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis